Related Experiment Video
Updated: Jan 20, 2026
08:45
Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring
Published on: November 13, 2012
14.3K
Selbstmanagement bei Krebstherapien fördern: Das Symptom-Navi-Programm
Susanne Kropf-Staub1, Manuela Eicher2, Jörg Haslbeck3,4
1Lindenhofgruppe, Bern.
Pflege
|August 24, 2019
Summary
The Symptom-Navi-Program (SNP) empowers cancer patients to manage treatment symptoms effectively. Patients found the program, including tailored information flyers and nurse consultations, useful for self-management and informed decision-making.
Area of Science:
- Oncology
- Patient Support
- Health Informatics
Background:
- Cancer patients frequently encounter diverse symptoms from disease and treatment.
- Many patients lack confidence in managing these symptoms independently.
- The Symptom-Navi-Program (SNP) was developed to address this need for enhanced symptom self-management support.
Purpose of the Study:
- To explore cancer patients' experiences with the Symptom-Navi-Program (SNP).
- To assess the perceived usefulness of the SNP in facilitating symptom self-management.
Main Methods:
- A qualitative study design was employed.
- Ten semi-structured interviews were conducted with cancer patients undergoing treatment.
- Thematic analysis, based on Braun and Clarke (2006), guided data analysis.
Main Results:
- Patients reported the SNP as a valuable tool for symptom self-management.
- Tailored information flyers (SNF) and nurse-led education were identified as empowering elements.
- Patients felt more informed and had greater autonomy in their symptom management strategies.
Conclusions:
- The Symptom-Navi-Program (SNP) shows promise in improving cancer symptom self-management.
- Further evaluation of the SNP's implementation in clinical practice is warranted.
Keywords:
KrebsPatientenedukationSymptommanagementcancerpatient educationsymptom managementthematic analysisthematische AnalyseMore Related Videos
10:45A Community-based Stress Management Program: Using Wearable Devices to Assess Whole Body Physiological Responses in Non-laboratory Settings
Published on: January 22, 2018
8.0K
10:16Promoter Capture Hi-C: High-resolution, Genome-wide Profiling of Promoter Interactions
Published on: June 28, 2018
33.4K
Related Concept Videos
01:28Pleural Effusion II: Symptoms and Management
675
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
675
02:49Cancer Therapies
9.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.9K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:40The Eukaryotic Promoter Region
18.7K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.7K
00:59Gene Therapy
27.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.1K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K